Pharmaceutical Investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
Pharmaceutical Investing Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag)
Walker Lane Resources: Advancing High-grade Gold, Silver assets in North America’s Prolific Regions
Cartier Resources Closes Offering with Paradigm Capital and Concurrent Offering for Aggregate Gross Proceeds of $11,398,596
